ストックスクリーナーアプリを入手
4.865
4.04%
-0.205
前日終値:
$5.07
開ける：
$5.1
24時間の取引高:
890.09K
Relative Volume:
0.48
時価総額：
$486.42M
収益：
$545.76M
当期純損益:
$-36.28M
株価収益率:
-12.96
EPS:
-0.3754
ネットキャッシュフロー:
$-25.73M
1週間 パフォーマンス:
-2.31%
1か月 パフォーマンス:
-10.41%
6か月 パフォーマンス:
+79.52%
1年 パフォーマンス:
+32.56%
1日の値動き範囲:
$4.86
$5.25
1週間の範囲:
$4.70
$5.32
52週間の値動き範囲:
$2.32
$6.67
Oncology Institute Inc Stock (TOI) Company Profile
Compare TOI vs HCA, THC, DVA, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
4.865 | 518.91M | 545.76M | -36.28M | -25.73M | -0.3754 |
HCA
Hca Healthcare Inc
|
402.58 | 86.43B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
254.84 | 20.96B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
240.11 | 15.17B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
25.67 | 13.36B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
111.08 | 11.30B | 6.07B | 793.80M | 464.40M | 5.9914 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-25 | 開始されました | Needham | Buy |
| 2025-07-23 | 開始されました | Noble Capital Markets | Outperform |
| 2025-07-16 | 開始されました | B. Riley Securities | Buy |
| 2025-05-15 | 開始されました | BTIG Research | Buy |
| 2024-02-26 | 再開されました | Jefferies | Buy |
| 2022-09-14 | 開始されました | Guggenheim | Buy |
| 2022-08-15 | 開始されました | Jefferies | Buy |
すべてを表示
Oncology Institute Inc (TOI) 最新ニュース
The Oncology Institute Announces Second Quarter 2026 Financial Results Conference Call - Quiver Quantitative
The Oncology Institute's Q2 results call will stream online Aug. 6 - Stock Titan
Oncology Institute Inc (TOI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oncology Institute Inc (TOI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Oncology Institute Inc (TOI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Oncology Institute Inc (TOI) Income Statement - TradingKey
Oncology Institute Inc (TOI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Oncology Institute Inc (TOI) Cash Flow - TradingKey
Oncology Institute Inc (TOI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Oncology Institute Inc (TOI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
The Oncology Institute Inc. (TOI) Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline, Revenue Uncertainty Caps StockCFO Commentary Report - dars.gov.et
Insider Buying: Jorey Chernett Acquires Additional Shares of The Oncology Institute Inc (TOI) - GuruFocus
The Oncology Institute (TOI) Sheds Nearly 2% Amidst Sector Headwinds, Support TestedLeading Diagonal - dars.gov.et
Oncology Institute, Inc. (TOI) 10% owner adds 18,000 shares in open-market buy - Stock Titan
Oncology Institute CMO Yale Podnos disposes of 23,452 common shares worth $150,362.95 - Bitget
Oncology institute CMO Yale Podnos sells $150k in shares By Investing.com - Investing.com South Africa
Form 4 Oncology Institute Inc For: 16 July By Investing.com - Investing.com Nigeria
Oncology Institute, Inc. (TOI) CMO sells 23,452 shares after option exercises - Stock Titan
Oncology institute CMO Yale Podnos sells $150k in shares - Investing.com
Is Oncology Institute (TOI) One of the Best Future Stocks to Buy Under $10? - Yahoo Finance
The Oncology Institute Inc. (TOI) Q1 2026 Earnings: Wider-Than-Expected Loss Narrows on Strong Cost ControlsUpward Estimate Revision - dars.gov.et
The Oncology Institute Warrant (TOIIW) Stalls at $0.07 as Trading Remains FlatETF Creation Redemption - dars.gov.et
Form 144 The Oncology Institute For: 14 July By Investing.com - Investing.com Nigeria
TOI (NASDAQ: TOI) plans sale of 23,452 shares worth $146,575.00 - Stock Titan
Form 4 Oncology Institute Inc For: 13 July By Investing.com - Investing.com Australia
Oncology institute: 10% owner Jorey Chernett buys $87,750 stock - Investing.com UK
Oncology institute: 10% owner Jorey Chernett buys $87,750 stock By Investing.com - Investing.com Nigeria
Oncology Institute (TOI) major holder buys 15,000 shares in open market - Stock Titan
DFPH SEC FilingsOncology Institute, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
The Oncology Institute (TOI) Proxy filing Summary - Quartr
TOIIW SEC FilingsThe Oncology Institute Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Oncology Institute (TOI) Short Interest & Short Float | Updated Jul 2026 $TOI - MarketBeat
Oncology Institute Price Target Raised to $9.00/Share From $8.00 by BTIG - Moomoo
Oncology Institute (TOI) director receives 17,185-share fully vested RSU grant - Stock Titan
Oncology Institute (TOI) director receives 25,833 fully vested RSU shares - Stock Titan
TOI Maintained by BTIG -- Price Target Raised to $9.00 - GuruFocus
BTIG raises Oncology Institute stock price target to $9 on debt refinancing By Investing.com - Investing.com South Africa
BTIG raises Oncology Institute stock price target to $9 on debt refinancing - Investing.com Nigeria
BTIG Maintains The Oncology Institute(TOI.US) With Buy Rating, Raises Target Price to $9 - Moomoo
Oncology Institute Refinances Debt with New Term Loan - TipRanks
Oncology Institute (NASDAQ: TOI) adds $75M OrbiMed loan in major refi - Stock Titan
Needham Maintains The Oncology Institute(TOI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Oncology Institute refinances $86m debt with OrbiMed By Investing.com - Investing.com Nigeria
Enterprise value to revenue forward of The Oncology Institute, Inc. – NASDAQ:TOI - TradingView
Oncology Institute Inc (TOI) 財務データ
収益
当期純利益
現金流量
EPS
Oncology Institute Inc (TOI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Podnos Yale | Chief Medical Officer |
Jul 14 '26 |
Option Exercise |
1.90 |
23,452 |
44,567 |
277,501 |
| Podnos Yale | Chief Medical Officer |
Jul 14 '26 |
Sale |
6.41 |
23,452 |
150,340 |
259,527 |
0.03%
0.48%
大文字化:
|
ボリューム (24 時間):